Heparin attenuates lipopolysaccharide-induced acute lung injury by inhibiting nitric oxide synthase and TGF-β/Smad signaling pathway

Thrombosis Research

Volumn 129, Issue 4, 2012, Pages 479-485

  Mu, En ^a   Ding, Renyu ^a   An, Xin ^a   Li, Xin ^a   Chen, Song ^a   Ma, Xiaochun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Acute lung injury; Heparin; Lipopolysaccharide; Nitric oxide synthase; TGF Smad

Indexed keywords

HEPARIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MALONALDEHYDE; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; LUNG EDEMA; LUNG WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ACUTE LUNG INJURY; ANIMALS; ANTICOAGULANTS; HEPARIN; LIPOPOLYSACCHARIDES; NITRIC OXIDE SYNTHASE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 84858341456     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.10.003     Document Type: Article

References (34)

1. L.B. Ware, and M.A. Matthay The acute respiratory distress syndrome N Engl J Med 342 2000 1334 1349
2. M.A. Matthay, and R.L. Zemans The acute respiratory distress syndrome: pathogenesis and treatment Annu Rev Pathol 6 2011 147 163
3. M.A. Matthay, and G.A. Zimmerman Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management Am J Respir Cell Mol Biol 33 2005 319 327
4. S.E. Erickson, G.S. Martin, J.L. Davis, M.A. Matthay, and M.D. Eisner Recent trends in acute lung injury mortality: 1996-2005 Crit Care Med 37 2009 1574 1579
5. J.J. Zimmerman, S.R. Akhtar, E. Caldwell, and G.D. Rubenfeld Incidence and outcomes of pediatric acute lung injury Pediatrics 124 2009 87 95
6. R. Lever, and C.P. Page Novel drug development opportunities for heparin Nat Rev Drug Discov 1 2002 140 148
7. A.D. Fryer, and D.B. Jacoby Function of pulmonary M2 muscarinic receptors in antigen-challenged guinea pigs is restored by heparin and poly-L-glutamate J Clin Invest 90 1992 2292 2298
8. R.L. Barker, R.H. Gundel, G.J. Gleich, J.L. Checkel, D.A. Loegering, and L.R. Pease Acidic polyamino acids inhibit human eosinophil granule major basic protein toxicity. Evidence of a functional role for ProMBP J Clin Invest 88 1991 798 805
9. E. Abraham Coagulation abnormalities in acute lung injury and sepsis Am J Respir Cell Mol Biol 22 2000 401 404
10. M. Wang, J. He, B. Mei, X. Ma, and Z. Huo Therapeutic effects and anti-inflammatory mechanisms of heparin on acute lung injury in rabbits Acad Emerg Med 15 2008 656 663
11. M.A. Marletta Nitric oxide synthase: aspects concerning structure and catalysis Cell 78 1994 927 930
12. A. Kobayashi, S. Hashimoto, K. Kooguchi, Y. Kitamura, H. Onodera, and Y. Urata Expression of inducible nitric oxide synthase and inflammatory cytokines in alveolar macrophages of ARDS following sepsis Chest 113 1998 1632 1639
13. H.M. Razavi, R. Werhun, J.A. Scott, S. Weicker, F. Wang le, and D.G. McCormack Effects of inhaled nitric oxide in a mouse model of sepsis-induced acute lung injury Crit Care Med 30 2002 868 873
14. R.P. Lee, D. Wang, S.J. Kao, and H.I. Chen The lung is the major site that produces nitric oxide to induce acute pulmonary oedema in endotoxin shock Clin Exp Pharmacol Physiol 28 2001 315 320
15. S.C. Wesselkamper, L.M. Case, L.N. Henning, M.T. Borchers, J.W. Tichelaar, and J.M. Mason Gene expression changes during the development of acute lung injury: role of transforming growth factor beta Am J Respir Crit Care Med 172 2005 1399 1411
16. M. Kolb, P.J. Margetts, D.C. Anthony, F. Pitossi, and J. Gauldie Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis J Clin Invest 107 2001 1529 1536
17. R.J. Fahy, F. Lichtenberger, C.B. McKeegan, G.J. Nuovo, C.B. Marsh, and M.D. Wewers The acute respiratory distress syndrome: a role for transforming growth factor-beta 1 Am J Respir Cell Mol Biol 28 2003 499 503
18. C. Ritter, A.A. da Cunha, I.C. Echer, M. Andrades, A. Reinke, and N. Lucchiari Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide- induced acute lung injury in the rat Crit Care Med 34 2006 471 477
19. A.A. da Cunha, F.B. Nunes, A. Lunardelli, V. Pauli, R.H. Amaral, and L.M. de Oliveira Treatment with N-methyl-d-aspartate receptor antagonist (MK-801) protects against oxidative stress in lipopolysaccharide-induced acute lung injury in the rat Int Immunopharmacol 11 2011 706 711
20. G. Li, J. Li, Q. Zhou, X. Song, H. Liang, and L. Huang Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats Tohoku J Exp Med 222 2010 7 13
21. L.D. Hudson, J.A. Milberg, D. Anardi, and R.J. Maunder Clinical risks for development of the acute respiratory distress syndrome Am J Respir Crit Care Med 151 1995 293 301
22. D. Karmpaliotis, I. Kosmidou, E.P. Ingenito, K. Hong, A. Malhotra, and M.E. Sunday Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury Am J Physiol Lung Cell Mol Physiol 283 2002 L585 L595
23. R.B. Goodman, J. Pugin, J.S. Lee, and M.A. Matthay Cytokine-mediated inflammation in acute lung injury Cytokine Growth Factor Rev 14 2003 523 535
24. T. Minamino, and I. Komuro Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury J Clin Invest 116 2006 2316 2319
25. C.L. Speyer, T.A. Neff, R.L. Warner, R.F. Guo, J.V. Sarma, and N.C. Riedemann Regulatory effects of iNOS on acute lung inflammatory responses in mice Am J Pathol 163 2003 2319 2328
26. K.S. Farley, L.F. Wang, H.M. Razavi, C. Law, M. Rohan, and D.G. McCormack Effects of macrophage inducible nitric oxide synthase in murine septic lung injury Am J Physiol Lung Cell Mol Physiol 290 2006 L1164 L1172
27. L.F. Wang, S. Mehta, S. Weicker, J.A. Scott, M. Joseph, and H.M. Razavi Relative contribution of hemopoietic and pulmonary parenchymal cells to lung inducible nitric oxide synthase (inos) activity in murine endotoxemia Biochem Biophys Res Commun 283 2001 694 699
28. T. Iuvone, F. D'Acquisto, R. Carnuccio, and M. Di Rosa Nitric oxide inhibits LPS-induced tumor necrosis factor synthesis in vitro and in vivo Life Sci 59 1996 PL207 PL211
29. L.M. Foley, T.K. Hitchens, J.A. Melick, H. Bayir, C. Ho, and P.M. Kochanek Effect of inducible nitric oxide synthase on cerebral blood flow after experimental traumatic brain injury in mice J Neurotrauma 25 2008 299 310
30. M. Lange, P. Enkhbaatar, Y. Nakano, and D.L. Traber Role of nitric oxide in shock: the large animal perspective Front Biosci 14 2009 1979 1989
31. E. Bonmann, E. Juttler, H.E. Krestel, and M. Spranger Heparin inhibits induction of nitric oxide synthase by cytokines in rat brain microvascular endothelial cells Neurosci Lett 253 1998 95 98
32. R. Derynck, Y. Zhang, and X.H. Feng Smads: transcriptional activators of TGF-beta responses Cell 95 1998 737 740
33. Q. Lu, E.O. Harrington, H. Jackson, N. Morin, C. Shannon, and S. Rounds Transforming growth factor-beta1-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation J Appl Physiol 101 2006 375 384
34. J.H. Lee, H. Lee, Y.K. Joung, K.H. Jung, J.H. Choi, and D.H. Lee The use of low molecular weight heparin-pluronic nanogels to impede liver fibrosis by inhibition the TGF-beta/Smad signaling pathway Biomaterials 32 2011 1438 1445